Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-12 for Chronic Cryptosporidiosis in AIDS
NCT00001128Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Jun 2005
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cryptosporidiosis comparing IL-12 + Backbone with Placebo + Backbone (2 arms). Status: terminated.
02
Drugs
recombinant interleukin-12
03
Conditions
cryptosporidiosis
Beyond the preview
Go deeper on NCT00001128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001128.